Hiu Fung Yip

Bio-Mol improves small molecule property prediction by integrating missing bioactivity profiles through pretraining and finetuning, achieving a 5.2% higher AUROC than previous models.

This study uses an explainable AI model to classify chronic inflammatory responses as prognostic markers for glioma using TCGA data, identifying five inflammatory profiles linked to survival outcomes.

ReDisX redefines disease diagnosis by classifying patients based on genomic signatures, revealing disease subpopulations and identifying GZMB as a potential drug repurposing marker.